Human Immunodeficiency Virus 1 Capsid Inhibitor
- Name
- Human Immunodeficiency Virus 1 Capsid Inhibitor
- Accession Number
- DBCAT005911
- Description
Not Available
- Drugs
Drug Drug Description Lenacapavir A first-in-class capsid inhibitor being investigated for use in HIV-1 treatment. - Drugs & Drug Targets
Drug Target Type Lenacapavir Gag-Pol polyprotein target Lenacapavir Cytochrome P450 3A4 enzyme Lenacapavir UDP-glucuronosyltransferase 1-1 enzyme Lenacapavir P-glycoprotein 1 transporter